Potential role of nutraceutical compounds in inflammatory bowel disease

doi:10.3748/wjg.v23.i14.2483

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14656)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

1116

WORD

562

HTML

7706

Figures (1-2)

285

Tables (1-1)

240

Sum=9909

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

895

Download

1096

Sum=1991

Publishing Process of This Article

Item

Count

Browse

1201

Download

1555

Sum=2756

Apr 14, 2017 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (69)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Apr 14, 2017; 23(14): 2483-2492
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2483

Open in New Tab Full Size Figure Download Figure

Figure 1 Macro-categories of Nutraceuticals and related most representative compounds.

Open in New Tab Full Size Figure Download Figure

Figure 2 Phytochemicals and their interactions with inflammatory pathways. IFN-γ: Interferon-gamma; IL: Interleukin; MIF: Macrophage migration inhibitory factor; NF-κB: Nuclear factor kappa-light-chain-enhancer of activated B cells; TNF-α: Tumor necrosis factor-alpha.

Citation: Larussa T, Imeneo M, Luzza F. Potential role of nutraceutical compounds in inflammatory bowel disease. World J Gastroenterol 2017; 23(14): 2483-2492
URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2483.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2483